GENE ONLINE|News &
Opinion
Blog

CAR T-cell Therapy
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
ASCO21: Current Issues with CAR T Cells for Hematologic Malignancies
2021-06-08
Day 1 ASCO 2021 Roundup: Combating Lung Cancer, Hematologic Malignancies and Advanced Solid Tumors
2021-06-05
R&D Cancer Therapy
A Glance at Gene Therapy Advances in Cancer
2021-05-16
R&D
Recent Advances in CAR T-Cell Therapy Development
2021-04-14
M&A CAR T-cell Therapy
Sanofi to Go After mRNA Based Cancer Treatments, Acquires Cambridge Startup for $470 Million
2021-04-12
Funding oNK Cell Therapy
Acepodia Raises $47 Million Funding to Nurture its Next-Gen, oNK Cell Therapy Assets
2021-03-17
Trials & Approvals CAR T-cell Therapy
Gilead’s Breakthrough CAR-T Becomes First to Get FDA Approval for Indolent Follicular Lymphoma
2021-03-07
R&D CAR-T Technology
Interferon-γ Pathway Helps Cancer Cells Evade Immune Therapy
2021-02-28
R&D
AbbVie Signs Off-the-Shelf CAR-T Therapy Pact with Jennifer Doudna’s Caribou Biosciences
2021-02-11
China’s Gracell Biotechnologies, a CAR-T Therapy Company, Targets 150 Million for IPO
2021-01-13
R&D
ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
2020-12-07
Trials & Approvals
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
1 2 3 4
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top